Results 161 to 170 of about 188,311 (274)

Dynamics of hyperglycemia of patients treated with alpelisib: exploratory interim analysis of ITACA trial. [PDF]

Oncologist
Pancirov M, Flam J, Šuto Pavičić J, Čerina Pavlinović D, Dedić Plavetić N, Podolski P, Bajić Ž, Krnić M, Vrdoljak E.   +8 more
europepmc   +1 more source

1379 RATES AND ASSOCIATED RISK FACTORS FOR DLOW INDUCED HYPERGLYCEMIA (HG) IN NEONATES [PDF]

, 1981
Allen A. Mitchell, Carol Louik, Michael F. Epstein, Dennis Slone, Peter Goldman, Samuel Shapiro   +5 more
openalex   +1 more source

Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
Abstract Accurate kidney function assessment is essential for medication dosing, although traditional methods such as urine output and serum creatinine are limited, especially in patients with acute kidney injury. Cystatin C was made available as an alternative marker at our institution, prompting the formation of a multidisciplinary task force to ...
Victoria Williams, Rupal Parbhoo, Bruce Doepker, Claire Murphy, Lynn Wardlow, Kevin Kissling, Megan Bond, Kelly Bartsch, Sree Satyapriya, Markisha Wilder, Jessica Greco, Anthony Gerlach   +11 more
wiley   +1 more source

EFFECT OF HYPERGLYCEMIA ON MYOCARDIAL FUNCTION AS WELL AS RED BLOOD CELL PARAMETERS IN THE FETAL LAMB [PDF]

, 1984
Harry Bard, Jean‐Claude Fouron, X. De Muylder   +2 more
openalex   +1 more source

Mechanisms and therapeutic opportunities in metabolic aberrations of diabetic wounds: a narrative review. [PDF]

Cell Death Dis
Xiong Y, Knoedler S, Alfertshofer M, Kim BS, Jiang D, Liu G, Rinkevich Y, Mi B.   +7 more
europepmc   +1 more source

MYOCARDIAL GLYCOGEN METABOLISM IS MODIFIED DURING CHRONIC HYPERGLYCEMIA AND HYPERINSULINEMIA IN THE FETAL LAMB [PDF]

, 1984
David Warburton
openalex   +1 more source

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis, Elijah J. Weber, Cara Nelson, Ann R. Qin, Timothy R. Watkins, Ahmed A. Othman   +5 more
wiley   +1 more source

SHRs, biomarkers for dysregulated stress response, predict prognosis in sepsis patients: a retrospective cohort study from MIMIC-IV database. [PDF]

BMC Infect Dis
Lian H, Wang G, Zhang H, Wang X, He W.
europepmc   +1 more source

Early detection of cerebrospinal fluid/serum glucose ratio: A promising value for mortality prognosis in patients with acute bacterial meningitis

Journal of General and Family Medicine, EarlyView.
This study revealed that a glucometer‐based measurement significantly improved the turnaround time required for CSF/serum glucose ratio measurement compared to conventional laboratory tests, which could be considered a reliable aid to the mortality prognosis.
Nasrin Khodashenas, Rouzbeh Rajaei Ghafouri, Asghar Jafari Rouhi, Moloud Balafar   +3 more
wiley   +1 more source

The association between stress hyperglycemia ratio and 1-year outcomes in patients with acute myocardial infarction: a retrospective large sample cohort study. [PDF]

Front Endocrinol (Lausanne)
Yan N, Wu P, Zhang Z, Wang M, Ma J, Ma A, Chen D, Ma X, Li X.   +8 more
europepmc   +1 more source